Effect of P2Y12 Inhibitors, SGLT2 Inhibitors and P-Selectin Inhibitors on One-year Quality-of-Life Outcomes in Critically Ill Patients Hospitalized for COVID-19: A Pre-specified Secondary Analysis of the ACTIV4a Randomized Clinical Trial

Category Primary study
JournalAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Year 2025
This article has no abstract
Epistemonikos ID: d3019fb701c593d54aa4eedb1de879d496f9f4d6
First added on: Jul 15, 2025